17283-12-4

Basic information

• Product Name: 3-4-dimethylpropiophenone
• Synonyms: 3-4-dimethylpropiophenone;1-(3,4-dimethylphenyl)propan-1-one(SALTDATA: FREE);Propiophenone, 3^,4^-dimethyl-
• CAS NO: 17283-12-4
• Molecular Formula: C₁₁H₁₄O
• Molecular Weight: 162.231
• Mol File: 17283-12-4.mol

Chemical Properties

• Boiling Point: 260.6°C at 760 mmHg
• Flash Point: 105°C
• Appearance: /
• Density: 0.954g/cm³
• Vapor Pressure: 0.0121mmHg at 25°C
• Refractive Index: 1.506
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-4-dimethylpropiophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 3-4-dimethylpropiophenone(17283-12-4)
• EPA Substance Registry System: 3-4-dimethylpropiophenone(17283-12-4)

Safety Data

• Hazardous Substances Data: 17283-12-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-4-dimethylpropiophenone is used as a precursor in the production of various pharmaceuticals for its ability to be easily modified and incorporated into complex molecular structures. Its versatility in organic synthesis allows for the development of new drugs with specific therapeutic properties.
Used in Fragrance Industry:
3-4-dimethylpropiophenone is used as a key ingredient in the creation of fragrances due to its strong, sweet odor. It contributes to the development of unique and appealing scents in perfumes, colognes, and other scented products.
Used in Flavoring Industry:
3-4-dimethylpropiophenone is used as a flavoring agent in the food and beverage industry. Its distinct sweet aroma adds depth and complexity to a variety of flavors, enhancing the taste profiles of various products.
Used in Organic Synthesis Research:
3-4-dimethylpropiophenone is used as a commonly employed chemical in research and laboratory settings for its versatility in creating different compounds. It serves as a valuable intermediate in the synthesis of a wide range of organic compounds, facilitating the development of new materials and chemical processes.

InChI:InChI=1/C11H14O/c1-4-11(12)10-6-5-8(2)9(3)7-10/h5-7H,4H2,1-3H3

Upstream product

• 5973-71-7 3,4-dimethylbenzaldehyde 
• 104174-13-2 3,4-Xylyl-aethylcarbinol 
• 95-47-6 o-xylene 
• 123-62-6 propionic acid anhydride 
• 79-03-8 propionyl chloride 

Downstream Products

• 1226000-97-0 C₁₃H₁₆O₃ 
• 1202873-64-0 C₁₃H₁₆N₂O 
• 1097726-59-4 C₂₄H₂₈N₄O₃ 
• 1097726-51-6 C₂₄H₂₇N₃O₄ 
• 806601-27-4 (3,4-Dimethyl-phenyl)-(1-dimethylamino-ethyl)-keton 
• 847448-11-7 {[1-(3,4-dimethyl-phenyl)-propyl]-formyl-amino}-acetic acid methyl ester 
• 473732-70-6 1-(3,4-dimethylphenyl)propan-1-amine 

Relevant articles and documents

Palladium-promoted asymmetric cycloaddition reaction of arsole via an unusual exo-endo stereochemically controlled method

Asymmetric cycloaddition reaction between 3,4-dimethyl-1-phenylarsole and ethyl vinyl ketone was promoted by the palladium complex containing ortho-metalated (S)-[1-(dimethylamino)ethyl]naphthalene as the chiral auxiliary. The keto group in the resulting arsanorbornene cycloadducts could be located stereospecifically in the endo or exo position by controlling the electronic properties of the organopalladium promoter. In the intermolecular cycloaddition reaction, a pair of separable diastereomeric palladium complexes was obtained in the ratio of 2:1. In the intramolecular process, however, only one As-O bidentate arsanorbornene palladium complex was produced stereoselectively. The arsenic-elimination reaction was readily observed on the corresponding endo- and exo-ketoarsine ligands. The absolute configuration and the coordination property of the enantiomerically pure endo-cycloadduct had been established by single-crystal X-ray analysis.

Novel benzene-based carbamates for ache/bche inhibition: Synthesis and ligand/structure-oriented sar study

A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl-and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl-compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure–activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host–target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula I wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.